# Vasopressin Hemodynamic Response as a Septic Shock Subphenotype Indicator

> **NCT06426407** · — · TERMINATED · sponsor: **The Cleveland Clinic** · enrollment: 2 (actual)

## Conditions studied

- Shock, Septic

## Interventions

- **DRUG:** Vasopressin

## Key facts

- **NCT ID:** NCT06426407
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2025-10-01
- **Primary completion:** 2026-02-01
- **Final completion:** 2026-02-01
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** The study was terminated due to lack of feasibility.
- **Last updated:** 2026-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06426407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06426407, "Vasopressin Hemodynamic Response as a Septic Shock Subphenotype Indicator". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06426407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*